Latest Breaking News On - Amphastar pharmaceuticals - Page 6 : comparemela.com

LSV Asset Management Has $19 64 Million Position in Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH)

LSV Asset Management Has $19 64 Million Position in Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMichaela zasloffChina universal asset management coAnnex advisory servicesJpmorgan chase coAmphastar pharmaceuticals price performanceAmphastar pharmaceuticals company profileCovestor ltdNeedham companyNews ratings for amphastar pharmaceuticals dailySecurities exchange commissionQuarter for amphastar pharmaceuticalsNisa investment advisorsExchange commissionAmphastar pharmaceuticals incAmphastar pharmaceuticals

Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) Shares Purchased by LSV Asset Management

Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) Shares Purchased by LSV Asset Management
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMichaela zasloffNeedham companyMcglone suttner wealth management incAmphastar pharmaceuticals incAmphastar pharmaceuticalsAmphastar pharmaceuticals company profileSecurities exchange commissionChina universal asset management coInsider transactions at amphastar pharmaceuticalsNisa investment advisorsQuarter for amphastar pharmaceuticalsAmphastar pharmaceuticals price performanceLeeward financial partnersCovestor ltdJpmorgan chase co

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Company informationExchange commissionAmphastar pharmaceuticals incMost of the companyAmphastar pharmaceuticalsAnnual report

FTC targets Novo s Ozempic among 300-plus junk patents

FTC targets Novo s Ozempic among 300-plus junk patents
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca bydureonNorton waterfordNovo nordiskNovo wegovyCovis pharmaBoehringer ingelheimAmphastar pharmaceuticalsUs federal trade commissionTrade commissionFierce pharmaImpax laboratoriesOrange book

Amphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on Wednesday

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.73 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. […]

United statesFloydf petersenMichaela zasloffAmphastar pharmaceuticalsAmphastar pharmaceuticals incJpmorgan chase coAmphastar pharmaceuticals stock performanceNews ratings for amphastar pharmaceuticals dailyInsider transactions at amphastar pharmaceuticalsSecurities exchange commissionEarnings history for amphastar pharmaceuticalsNeedham companyGet free reportDirector floydExchange commissionDirector michael